[go: up one dir, main page]

BR9712675A - Agonistas do receptor de eritropoietina circularmente permutados. - Google Patents

Agonistas do receptor de eritropoietina circularmente permutados.

Info

Publication number
BR9712675A
BR9712675A BR9712675-6A BR9712675A BR9712675A BR 9712675 A BR9712675 A BR 9712675A BR 9712675 A BR9712675 A BR 9712675A BR 9712675 A BR9712675 A BR 9712675A
Authority
BR
Brazil
Prior art keywords
erythropoietin receptor
receptor agonists
exchanged
proteins
circularly exchanged
Prior art date
Application number
BR9712675-6A
Other languages
English (en)
Inventor
Charles A Mcwherter
Yiqing Feng
Neema Summers
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of BR9712675A publication Critical patent/BR9712675A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção:<B>"AGONISTAS DO RECEPTOR DE ERITROPOIETINA CIRCULARMENTE PERMUTADOS"<D>. São descritos novas proteínas agonistas do receptor da eritropoietina, DNA que codificam as proteínas agonitas do receptor da eritropoietina, métodos de preparação de proteínas agonistas do receptor de eritropoietina e métodos para o uso de proteínas agonistas do receptor de eritropoietina.
BR9712675-6A 1996-10-25 1997-10-23 Agonistas do receptor de eritropoietina circularmente permutados. BR9712675A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3404496P 1996-10-25 1996-10-25
PCT/US1997/018703 WO1998018926A1 (en) 1996-10-25 1997-10-23 Circularly permuted erythropoietin receptor agonists

Publications (1)

Publication Number Publication Date
BR9712675A true BR9712675A (pt) 1999-10-19

Family

ID=21873960

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712675-6A BR9712675A (pt) 1996-10-25 1997-10-23 Agonistas do receptor de eritropoietina circularmente permutados.

Country Status (13)

Country Link
US (1) US20060172932A1 (pt)
EP (1) EP0939816A1 (pt)
JP (1) JP2001503266A (pt)
KR (1) KR20000052807A (pt)
CN (1) CN1234073A (pt)
AU (1) AU721196B2 (pt)
BR (1) BR9712675A (pt)
CA (1) CA2268001A1 (pt)
CZ (1) CZ130199A3 (pt)
NO (1) NO991906L (pt)
NZ (1) NZ334546A (pt)
PL (1) PL189756B1 (pt)
WO (1) WO1998018926A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7309687B1 (en) 1999-04-13 2007-12-18 The Kenneth S. Warren Institute, Inc. Methods for treatment and prevention of neuromuscular and muscular conditions by peripherally administered erythropoietin
US7345019B1 (en) 1999-04-13 2008-03-18 The Kenneth S. Warren Institute, Inc. Modulation of excitable tissue function by peripherally administered erythropoietin
US6855544B1 (en) 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
US8236561B2 (en) 1999-04-15 2012-08-07 Crucell Holland B.V. Efficient production of IgA in recombinant mammalian cells
US7604960B2 (en) 1999-04-15 2009-10-20 Crucell Holland B.V. Transient protein expression methods
US7297680B2 (en) 1999-04-15 2007-11-20 Crucell Holland B.V. Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
US7192759B1 (en) 1999-11-26 2007-03-20 Crucell Holland B.V. Production of vaccines
US7527961B2 (en) 1999-11-26 2009-05-05 Crucell Holland B.V. Production of vaccines
US7521220B2 (en) 1999-11-26 2009-04-21 Crucell Holland B.V. Production of vaccines
US6531121B2 (en) 2000-12-29 2003-03-11 The Kenneth S. Warren Institute, Inc. Protection and enhancement of erythropoietin-responsive cells, tissues and organs
PA8536201A1 (es) 2000-12-29 2002-08-29 Kenneth S Warren Inst Inc Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
EP1465987B1 (en) 2001-12-07 2008-01-23 Crucell Holland B.V. Production of viruses, viral isolates and vaccines
JP4865539B2 (ja) 2003-05-09 2012-02-01 クルセル ホランド ベー ヴェー Ｅ１不死化細胞の培養物及び該培養物を培養して該培養物から得られる産物の収量を増加させる方法
US20090311247A1 (en) * 2005-01-25 2009-12-17 Apollo Life Sciences Limited Molecules and chimeric molecules thereof
PT1973559E (pt) 2005-11-23 2013-02-19 Acceleron Pharma Inc Antagonistas de activina-actriia e utilizações para promover o crescimento ósseo
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
WO2007060213A2 (en) * 2005-11-24 2007-05-31 Laboratoires Serono S.A. Erythropoietin polypeptides and uses thereof
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
CN103920139B (zh) 2007-02-01 2018-02-02 阿塞勒隆制药公司 活化素‑actriia拮抗剂及在治疗或预防乳腺癌中的用途
TW201940502A (zh) 2007-02-02 2019-10-16 美商艾瑟勒朗法瑪公司 衍生自ＡｃｔＲＩＩＢ的變體與其用途
TWI667038B (zh) 2007-02-09 2019-08-01 美商艾瑟勒朗法瑪公司 包含ＡｃｔＲＩＩａ-Ｆｃ融合蛋白的醫藥組合物；ＡｃｔＲＩＩａ-Ｆｃ融合蛋白於治療或預防與癌症相關的骨質流失之用途；ＡｃｔＲＩＩａ-Ｆｃ融合蛋白於治療或預防多發性骨髓瘤之用途
US7960343B2 (en) 2007-09-18 2011-06-14 Acceleron Pharma Inc. Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
TWI748373B (zh) 2008-08-14 2021-12-01 美商艾瑟勒朗法瑪公司 使用gdf阱以增加紅血球水平
CN102482339B (zh) 2009-06-08 2015-06-17 阿塞勒隆制药公司 用于增加产热脂肪细胞的方法
KR20210034684A (ko) 2009-06-12 2021-03-30 악셀레론 파마 인코포레이티드 절두된 ＡｃｔＲＩＩＢ-ＦＣ 융합 단백질
JP6267425B2 (ja) 2009-11-17 2018-01-24 アクセルロン ファーマ， インコーポレイテッド 筋ジストロフィー治療のためのユートロフィン誘導に関するａｃｔｒｉｉｂタンパク質およびその改変体およびその使用
KR20130132824A (ko) 2010-11-08 2013-12-05 악셀레론 파마 인코포레이티드 Actriia 결합제 및 이의 용도
CA2869674A1 (en) 2012-06-08 2013-12-12 Alkermes, Inc. Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
MX389254B (es) 2012-11-02 2025-03-20 Celgene Corp Antagonistas de activina-actrii y usos para tratar trastornos oseos y otros.
AP2017009674A0 (en) 2014-06-13 2017-01-31 Acceleron Pharma Inc Methods and compositions for treating ulcers
MA41052A (fr) 2014-10-09 2017-08-15 Celgene Corp Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
ES2946160T3 (es) 2014-12-03 2023-07-13 Celgene Corp Antagonistas de activina-ActRII y usos para tratar síndrome mielodisplásico
CN110144010B9 (zh) * 2018-02-14 2021-01-05 上海洛启生物医药技术有限公司 阻断型pd-l1驼源单域抗体及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751180A (en) * 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
JPH05502463A (ja) * 1990-09-28 1993-04-28 オーソ・フアーマシユーチカル・コーポレーシヨン ハイブリツド成長因子
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5635599A (en) * 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands

Also Published As

Publication number Publication date
WO1998018926A1 (en) 1998-05-07
AU5081098A (en) 1998-05-22
PL189756B1 (pl) 2005-09-30
US20060172932A1 (en) 2006-08-03
CN1234073A (zh) 1999-11-03
PL332960A1 (en) 1999-10-25
NZ334546A (en) 2000-12-22
KR20000052807A (ko) 2000-08-25
AU721196B2 (en) 2000-06-29
EP0939816A1 (en) 1999-09-08
JP2001503266A (ja) 2001-03-13
NO991906D0 (no) 1999-04-21
CZ130199A3 (cs) 1999-07-14
CA2268001A1 (en) 1998-05-07
NO991906L (no) 1999-04-21

Similar Documents

Publication Publication Date Title
BR9712675A (pt) Agonistas do receptor de eritropoietina circularmente permutados.
CY1112101T1 (el) Νευροτροφικοι παραγοντες
CA2251842A1 (en) Small molecule mimetics of erythropoietin
ES2149149T1 (es) Proteinas de fijacion de interleuquina-18, su preparacion y utilizacion.
BR9811039A (pt) Citocina de mamìferos: interleucina-b30 e reagentes relacionados
BR9714355A (pt) Novos agonistas de receptor flt3
ATE329028T1 (de) Nl3 tie rezeptortyrosinekinase ligandhomologe
BR9808646A (pt) Sequenciador de gene e processos
BR9812096A (pt) Proteìna receptora/ligante solúvel interleucina-6 quimérica, seus análogos e seus usos
BR0109060A (pt) Método para colorir cabelos usando corantes catiÈnicos
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
BRPI0413426A (pt) antagonistas de receptor novo
ATE342976T1 (de) Cytokinrezeptor-kette
BR9713668A (pt) Agonistas de receptores hematopoiéticos quiméricos multifuncionais
IL145689A0 (en) Methods
AU2001238212A1 (en) Modified fluorescent proteins
DK1082423T3 (da) Cyclin E2-gener og -proteiner
MX9802730A (es) Agonistas receptores hematopoyeticos multifuncionales.
MX9703364A (es) Peptidos capaces de unirse al dominio sh3 de la proteina gap, secuencias nucleotidicas que codifican para estos peptidos, su preparacion y su uso.
WO2003018631A3 (en) Nogo receptor homologues and their use
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
BR9910787A (pt) Métodos e composições úteis para modulação deangiogênese usando tirosina cinase src
SE9602822D0 (sv) New receptor
BR9808514A (pt) Proteìnas quiméricas do ligante flt3
AR065908A2 (es) Una composicion inmunogenica que comprende un polipeptido quimerico codificado por una molecula portadora que contiene una secuencia polinucleotidica que codifica en parte una glicoproteina de lyssavirus, polipeptidos, la molecula portadora, un metodo para la preparacion in vitro o in vivo de unpoli

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO, DE ACORDO COM ARTIGO 8O DA LPI

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C12N 15/18; C07K 14/505; C07K 14/52; A61K 38/18; C12N 5/10; C12N 5/08.

Ipc: C07K 14/505 (2006.01), A61K 38/00 (2006.01)

Ipc: C07K 14/505 (2006.01), A61K 38/00 (2006.01)